MAPT and Alzheimer disease: This ligand binds to Tau aggregates in Alzheimer's disease, in proportion to disease severity (Brier et al., 2016, Passamonti et al., 2017), and mirrors the distribution of pathology and functional deficits in variant presentations of Alzheimer's disease (Ossenkoppele et al., 2016).